STOCK TITAN

Reflect Scientific Inc. Releases Second Quarter 2022 Financials

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Reflect Scientific, Inc. (RSCF) reported its financial results for Q2 2022, with revenue at $555,615, down $151,518 from $707,133 in Q2 2021. The cost of goods sold decreased by $39,358, leading to a gross profit of $359,794, which fell by $112,160 year-over-year. Operating expenses totaled $281,669, down $19,656, resulting in a net income of $78,125, compared to a loss of $92,656 in the same period last year. Supply chain disruptions impacted product availability, but the CEO expects improvements by Q3.

Positive
  • Net income of $78,125, a significant recovery from a loss of $92,656 in Q2 2021.
  • Decrease in operating expenses by $19,656 from the previous year.
Negative
  • Revenue declined by $151,518 compared to Q2 2021.
  • Gross profit decreased by $112,160 year-over-year.
  • Supply chain issues affected product availability, posing ongoing risks.

OREM, Utah, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical, and transportation industries, today announced financial results for the second quarter of 2022.

“The supply chain issues plaguing U.S industries have recently affected some of the Reflect products. Although we anticipated much of the shipping delays and parts availability, we were finally hit with some shortages. We have been diligently researching workarounds and replacements. I do not expect this situation to extend past the third quarter.” stated Mr. Kim Boyce, CEO of Reflect Scientific.

The following unaudited table summarizes revenue, cost of goods sold, and operating expenses for the three months ended June 30, 2022 and 2021:

    
 Three Months
Ended June 30,
2022
Three Months
Ended June
30, 2021
Increase
(Decrease)
Revenue$555,615$707,133$(151,518)
Cost of Goods Sold 195,821 235,179 (39,358)
Gross Profit 359,794 471,954 (112,160)
Operating expenses:   
Salaries and wages 159,565 146,116 13,449 
Research and development expense 18,329 19,456 (1,127)
General and administrative expense 103,775 135,601 (31,826)
Total operating expenses 281,669 301,173 (19,656)
    
Income (loss) from operations 78,125 170,781 (92,656)
    
Net income (loss)$78,125$170,781$(92,656)

About Reflect Scientific, Inc.

Based in Orem, Utah, Reflect Scientific develops and markets innovative, proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical, and transportation markets. Among Reflect Scientific’s products are low-temperature freezers and refrigerated systems for laboratory, transportation, and computer server room uses. Visit reflectscientific.com for more information. See us on Twitter @ReflectSci and on LinkedIn at www.linkedin.com/company/reflect-scientific.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of the disclosures contained in the filings of the Company that are contained in the OTC Markets Group, LLC under the trading symbol “RSCF” and related prior filings by the Company that are referenced therein and contained in the EDGAR Archives of the Securities and Exchange Commission under the heading “Disclosure,” including those identified in such filings as “forward-looking statements.”


FAQ

What are Reflect Scientific's Q2 2022 financial results?

Reflect Scientific reported Q2 2022 revenue of $555,615, a decrease from $707,133 in Q2 2021.

What was the net income for Reflect Scientific in Q2 2022?

The net income for Q2 2022 was $78,125, compared to a loss of $92,656 in Q2 2021.

How did supply chain issues affect Reflect Scientific?

Supply chain disruptions led to product availability issues, though the CEO anticipates improvements by Q3 2022.

What were the operating expenses for Reflect Scientific in Q2 2022?

Operating expenses totaled $281,669 in Q2 2022, down by $19,656 from the previous year.

REFLECT SCIENTIFIC INC

OTC:RSCF

RSCF Rankings

RSCF Latest News

RSCF Stock Data

4.27M
85.66M
0.02%
Medical Instruments & Supplies
Healthcare
Link
United States of America
Orem